Highland Ophthalmology Associates LLC is categorized under Ophthalmologists in Newburgh, NY and active since 2000.
Highland Ophthalmology Associates LLC was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Mary Davidian at the company’s single location by writing to 304 Fullerton Avenue, Newburgh, New York NY 12550 or by phoning (845) 562-0138. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Highland Ophthalmology Associates LLC |
| Contact Person: | Mary Davidian |
| Address: | 304 Fullerton Avenue, Newburgh, New York 12550 |
| Phone Number: | (845) 562-0138 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Highland Ophthalmology Associates LLC was started in 2000 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mary Davidian for inquiries that concern Highland Ophthalmology Associates LLC by calling the company number (845) 562-0138, as your correspondence is most welcome. Additionally, the physical location of the single location of Highland Ophthalmology Associates LLC can be found at the coordinates as well as the street address 304 Fullerton Avenue in Newburgh, New York 12550.
For its online presence, you may visit Highland Ophthalmology Associates LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.